Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03908892
Other study ID # 2019KT1122
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 12, 2019
Est. completion date December 2022

Study information

Verified date August 2022
Source Guangzhou University of Traditional Chinese Medicine
Contact Yanjuan Zhu, Dr
Phone 86 20 81887233
Email zyjsophy@gzucm.edu.cn
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a randomized control trial evaluating the efficacy of zanthoxylum nitidum tincture on preventing progression of paronychia caused by afatinib from grade 1 to grade 2/3. Enrolled participates will randomly receive original treatment or original treatment plus zanthoxylum nitidum tincture immersion of the sick nail(s).


Recruitment information / eligibility

Status Recruiting
Enrollment 110
Est. completion date December 2022
Est. primary completion date December 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: 1. Pathologically or cytologically confirmed non-small cell lung cancer; 2. Undergoing treatment with afatinib; 3. With grade 1 paronychia; 4. Age between 18 to 80 years old; 5. Estimated life expectancy of more than months; 6. With the written informed consent. Exclusion Criteria: 1. Paronychia before afatinib treatment; 2. Grade 2 or severer paronychia; 3. Stop using afatinib or with reduced dose of afatinib; 4. Currently diagnosed with severe encephalopathy or psychiatric disorders affecting patients ability of self expression. 5. Has other legal, medical or ethical reasons that patients are not appropriate for clinical study.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
zanthoxylum nitidum tincture
Local application with zanthoxylum nitidum tincture soaked blocks for the sick nail(s) for 30 minutes, twice a day.
tetracycline ointment
Local use of 1% tetracycline ointment for the sick nail(s), 3 times a day

Locations

Country Name City State
China Guangdong Provincial Hospital of Chinese Medicine Guangzhou Guangdong

Sponsors (1)

Lead Sponsor Collaborator
Guangzhou University of Traditional Chinese Medicine

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Paronychia progress rate Incidence of grade 2 or more paronychia during paronychia treatment period will be reported. This period will be from randomization till paronychia relief or progression. Frequency of evaluation for paronychia will be everyday. Through study completion, an average of 10 days.
Secondary Time to paronychia progress The time elapsed from randomization to either the date of grade 2 or more paronychia occurrence, treatment completion, or last follow-up information. Frequency of evaluation for paronychia will be everyday. Through study completion, an average of 10 days.
Secondary Time to paronychia relief The time elapsed from randomization to either the date of paronychia relief, treatment completion, or last follow-up information. Paronychia relief is defined as that paronychia disappears. Frequency of evaluation for paronychia will be everyday. Through study completion, an average of 10 days.
See also
  Status Clinical Trial Phase
Completed NCT06411093 - Efficacy and Safety of Kinesiology Tape Wrapping for Paronychia Induced by Epidermal Growth Factor Receptor Inhibitors N/A
Recruiting NCT05639933 - Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors Phase 2
Completed NCT05165082 - The Efficacy of Topical Timolol Combined With Cryotherapy in EGFR Inhibitors-induced Paronychia - a Double-blinded, Intrapatient Left-to-right Controlled Study N/A
Recruiting NCT06140186 - Efficacy and Safety of Timolol for TKI Induced Paronychia Phase 3